These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39424569)

  • 1. Impact of the 100 days mission for vaccines on COVID-19: a mathematical modelling study.
    Barnsley G; Olivera Mesa D; Hogan AB; Winskill P; Torkelson AA; Walker DG; Ghani AC; Watson OJ
    Lancet Glob Health; 2024 Nov; 12(11):e1764-e1774. PubMed ID: 39424569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.
    Watson OJ; Barnsley G; Toor J; Hogan AB; Winskill P; Ghani AC
    Lancet Infect Dis; 2022 Sep; 22(9):1293-1302. PubMed ID: 35753318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A
    Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
    Pearson CAB; Bozzani F; Procter SR; Davies NG; Huda M; Jensen HT; Keogh-Brown M; Khalid M; Sweeney S; Torres-Rueda S; ; ; Eggo RM; Vassall A; Jit M
    PLoS Med; 2021 Oct; 18(10):e1003815. PubMed ID: 34606520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
    Moore S; Hill EM; Tildesley MJ; Dyson L; Keeling MJ
    Lancet Infect Dis; 2021 Jun; 21(6):793-802. PubMed ID: 33743847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pandemic burden in low-income settings and impact of limited and delayed interventions: A granular modelling analysis of COVID-19 in Kabwe, Zambia.
    Perez-Guzman PN; Chanda SL; Schaap A; Shanaube K; Baguelin M; Nyangu ST; Kanyanga MK; Walker P; Ayles H; Chilengi R; Verity R; Hauck K; Knock ES; Cori A
    Int J Infect Dis; 2024 Oct; 147():107182. PubMed ID: 39067669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
    Sandmann FG; Davies NG; Vassall A; Edmunds WJ; Jit M;
    Lancet Infect Dis; 2021 Jul; 21(7):962-974. PubMed ID: 33743846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study.
    Hogan AB; Winskill P; Ghani AC
    PLoS Med; 2020 Nov; 17(11):e1003377. PubMed ID: 33253211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the population effectiveness of interventions against COVID-19 in France: A modelling study.
    Ganser I; Buckeridge DL; Heffernan J; Prague M; Thiébaut R
    Epidemics; 2024 Mar; 46():100744. PubMed ID: 38324970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution.
    Agampodi S; Mogeni OD; Chandler R; Pansuriya M; Kim JH; Excler JL
    Expert Rev Vaccines; 2024; 23(1):761-772. PubMed ID: 39167221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Demographics Collaborators
    Lancet; 2024 May; 403(10440):1989-2056. PubMed ID: 38484753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical modelling of the 100-day target for vaccine availability after the detection of a novel pathogen: A case study in Indonesia.
    Bilgin GM; Munira SL; Lokuge K; Glass K
    Vaccine; 2024 Aug; 42(21):126163. PubMed ID: 39060201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study.
    Savinkina A; Bilinski A; Fitzpatrick M; Paltiel AD; Rizvi Z; Salomon J; Thornhill T; Gonsalves G
    BMJ Open; 2022 Sep; 12(9):e061752. PubMed ID: 36100306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study.
    Vilches TN; Abdollahi E; Cipriano LE; Haworth-Brockman M; Keynan Y; Sheffield H; Langley JM; Moghadas SM
    BMC Public Health; 2022 May; 22(1):1042. PubMed ID: 35614429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.
    Toor J; Echeverria-Londono S; Li X; Abbas K; Carter ED; Clapham HE; Clark A; de Villiers MJ; Eilertson K; Ferrari M; Gamkrelidze I; Hallett TB; Hinsley WR; Hogan D; Huber JH; Jackson ML; Jean K; Jit M; Karachaliou A; Klepac P; Kraay A; Lessler J; Li X; Lopman BA; Mengistu T; Metcalf CJE; Moore SM; Nayagam S; Papadopoulos T; Perkins TA; Portnoy A; Razavi H; Razavi-Shearer D; Resch S; Sanderson C; Sweet S; Tam Y; Tanvir H; Tran Minh Q; Trotter CL; Truelove SA; Vynnycky E; Walker N; Winter A; Woodruff K; Ferguson NM; Gaythorpe KA
    Elife; 2021 Jul; 10():. PubMed ID: 34253291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-pharmaceutical interventions in containing COVID-19 pandemic after the roll-out of coronavirus vaccines: a systematic review.
    He X; Chen H; Zhu X; Gao W
    BMC Public Health; 2024 Jun; 24(1):1524. PubMed ID: 38844867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.
    Jentsch PC; Anand M; Bauch CT
    Lancet Infect Dis; 2021 Aug; 21(8):1097-1106. PubMed ID: 33811817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study.
    Coudeville L; Jollivet O; Mahé C; Chaves S; Gomez GB
    PLoS One; 2021; 16(4):e0250797. PubMed ID: 33909687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adjusting public health, travel, and social measures during the roll-out of COVID-19 vaccination: a modelling study.
    Leung K; Wu JT; Leung GM
    Lancet Public Health; 2021 Sep; 6(9):e674-e682. PubMed ID: 34388389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.